Temasek, Yunfeng lead $75 million funding into China genomics firm

SHANGHAI Jack Ma’s private equity firm Yunfeng Capital and Singapore’s Temasek have led a $75 million fund-raising round into genomics company WuXi NextCODE, the firm said in a statement on Tuesday, underlining a race for medical data in China. WuXi …
( read original story …)


Related Post